BeiGene and Boehringer Ingelheim Announce Commercial Supply Agreement for Anti-PD-1 Antibody Tislelizumab
BeiGene, Ltd. and Boehringer Ingelheim Biopharmaceuticals (China) Ltd. announced that the two companies have entered into a commercial supply agreement...